Guggenheim Securities

1 articles
BenzingaBenzinga··Not Specified

JATT II Acquisition Corp Closes $60M IPO, Eyes Healthcare & Biotech Deals

JATT II Acquisition Corp closed a $60M IPO on NASDAQ under ticker $JATT, priced at $10/share, focusing on healthcare and biotech combinations via data-driven discovery approaches.
JATTZURAhealthcareIPO